US Patent Issued to Eli Lilly and Co. on July 1 for "Methods of using a GIP/GLP1 co-agonist for therapy" (Indiana Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,382, issued on July 1, was assigned to Eli Lilly and Co. (Indianapolis).

"Methods of using a GIP/GLP1 co-agonist for therapy" was invented by Charles T. Benson (Zionsville, Ind.), Axel Haupt (Zionsville, Ind.), Melissa Kay Thomas (Indianapolis) and Shweta Urva (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for increasing glycemic control in a patient in need thereof, by administering tirzepatide, or a pharmaceutically acceptable salt thereof. The present invention provides a method for improving weight management in a patient in need thereof, by administering tirzepatide, or a pharmaceutically acc...